Affimed Therapeutics AG - The discovery and development of next generation antibodies for the treatment of cancer and other diseases with unmet medical need.

Lady in sunshine

Recent News
05-06-2008
Affimed appoints Chief Business Officer
13-05-2008
Affimed validates antibody target for cancer metastasis
04-02-2008
Affimed Increases Series B Financing in Second Closing to Euro 30 Million (USD 45 Million)
04-04-2007
Affimed Closes € 25 M (US $ 32 M) Series B financing
04-12-2006
Affimed's fully human anti thrombosis antibody shows in vivo efficacy with reduced side effects
24-11-2006
Affimed obtains victory in challenge to key naive IgM-based antibody libraries patent
26-09-2006
Xoma and Affimed sign antibody cross-license and collaboration agreement agreement

Press Room

Downloadable Pictures / Logos

Downloadable Corporate Factsheet

Downloadable Corporate Presentation